1.
ANGPTL8 Blockade With a Monoclonal Antibody Promotes Triglyceride Clearance, Energy Expenditure, and Weight Loss in Mice
by Gusarova, Viktoria
Endocrinology (Philadelphia), 2017-05-01, Vol.158 (5), p.1252-1259

2.
Mechanism of Action of a Peroxisome Proliferator-Activated Receptor (PPAR)-δ Agonist on Lipoprotein Metabolism in Dyslipidemic Subjects with Central Obesity
by Ooi, Esther M. M
The journal of clinical endocrinology and metabolism, 2011-10, Vol.96 (10), p.E1568-E1576

3.
ApoA-II HDL Catabolism and Its Relationships With the Kinetics of ApoA-I HDL and of VLDL1, in Abdominal Obesity
by Vergès, Bruno
The journal of clinical endocrinology and metabolism, 2016-04, Vol.101 (4), p.1398-1406

4.
Sex Differences in Lipid and Lipoprotein Metabolism: It's Not Just about Sex Hormones
by Wang, Xuewen
The journal of clinical endocrinology and metabolism, 2011-04, Vol.96 (4), p.885-893

5.
Adsorption kinetics of low-density lipoproteins with Langmuir monolayer
by Khattari, Ziad
Journal of biological physics, 2016-07-19, Vol.42 (4), p.539-550

6.
Energy demands during a judo match and recovery
by Degoutte, F
British journal of sports medicine, 2003-06, Vol.37 (3), p.245-249

7.
Time-course changes in circulating branched-chain amino acid levels and metabolism in obese Yucatan minipig
by Polakof, Sergio
Nutrition (Burbank, Los Angeles County, Calif.), 2017, Vol.50, p.66-73

8.
Gender Differences in VLDL1 and VLDL2 Triglyceride Kinetics and Fatty Acid Kinetics in Obese Postmenopausal Women and Obese Men
by Sarac, Ivana
The journal of clinical endocrinology and metabolism, 2012-07, Vol.97 (7), p.2475-2481

9.
Isolated hyperglycaemia does not increase VLDL-triacylglycerol secretion in type 1 diabetic men
by Johansen, Rakel F
Diabetologia, 2014-11-11, Vol.58 (2), p.355-362

10.
Lipoprotein( a ) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis
by Hajjar, Katherine A
Nature (London), 1989-05-25, Vol.339 (6222), p.303-305

11.
Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins
by Kugiyama, Kiyotaka
Nature (London), 1990-03-08, Vol.344 (6262), p.160-162

12.
A potential basis for the thrombotic risks associated with lipoprotein( a )
by Miles, Lindsey A
Nature (London), 1989-05-25, Vol.339 (6222), p.301-303

13.
Tumor necrosis factor acutely increases plasma levels of very low density lipoproteins of normal size and composition
by KRAUSS, R. M
Endocrinology (Philadelphia), 1990, Vol.127 (3), p.1016-1021

14.
Minimally modified low density lipoproteins induce aortic smooth muscle cell proliferation via the activation of mitogen activated protein kinase
by Balagopalakrishna, C
Molecular and cellular biochemistry, 1997-05, Vol.170 (1-2), p.85-89

15.
Estrogen modulates the expression of L-arginine:glycine amidinotransferase in chick liver
by Zhu, Y
Molecular and cellular biochemistry, 2001-05, Vol.221 (1-2), p.139-145

16.
New variation on the translocation of proteins during early biogenesis of apolipoprotein B
by Chuck, Steven L
Nature (London), 1990-07-26, Vol.346 (6282), p.382-385

17.
Fluorescent probing of the ligand-binding ability of blood plasma in the acute-phase response
by IVANOV, A. I
Clinical and experimental medicine, 2002, Vol.2 (3), p.147-155

18.
The thyroxine-binding site of human apolipoprotein-A-I: location in the N-terminal domain
by Benvenga, S
Endocrinology (Philadelphia), 1991-01, Vol.128 (1), p.547-552

19.
Effect of the antiestrogen ethamoxytriphetol (MER-25) on placental low density lipoprotein uptake and degradation in baboons
by Henson, M C
Endocrinology (Philadelphia), 1988-05, Vol.122 (5), p.2019-2026

20.
Involvement of microtubules in lipoprotein degradation and utilization for steroidogenesis in cultured rat luteal cells
by RAJAN, V. P
Endocrinology (Philadelphia), 1985, Vol.117 (6), p.2408-2416
